A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants
A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants
Active, not recruiting · NCT07311226 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants | Healthy Participants | Active, not recruiting | Phase 1 | 2026-05-22 | NCT07311226 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai General Hospital | Shanghai | China | 59 |